ホーム 計算ツール
代理店ログイン

LILRB5/CD85c Protein, Human, Recombinant (hFc)

カタログ番号 TMPY-06273
別名: LIR-8, LIR8, CD85C, leukocyte immunoglobulin like receptor B5

A genetic variant in LILRB5 (leukocyte immunoglobulin-like receptor subfamily-B) (rs12975366: T < C: Asp247Gly) has been reported to be associated with lower creatine phosphokinase (CK) and lactate dehydrogenase (LDH) levels. Both biomarkers are released from injured muscle tissue, making this variant a potential candidate for susceptibility to muscle-related symptoms. LILRB5/CD85c Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 74.06 kDa and the accession number is O75023-1.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
LILRB5/CD85c Protein, Human, Recombinant (hFc)
パッケージサイズ 在庫状況 単価(税別)
100 μg 約5 days ¥ 161,000
1 mg 約5 days ¥ 1,049,000
ご確認事項

1. 1研究室・グループあたり最大5製品までお申し込みいただけます。 同一製品は1回のみとなります。

2. 1回につき最大2製品までのお申し込みが可能です。

3. 2回目以降をご希望の際は、前回ご提供のサンプルの実験結果をオンラインでご提供いただく必要がございます。

4. 2023 年 1 月 20 日より前にサンプルをお申し込みいただいたお客様は、2023 年の無料申請枠にはカウントされませんが、以前の実験結果をご提供いただく必要があります。

Get quote
Contact us for more batch information
生物学的特性に関する説明
Technical Params
Product Properties
説明 A genetic variant in LILRB5 (leukocyte immunoglobulin-like receptor subfamily-B) (rs12975366: T > C: Asp247Gly) has been reported to be associated with lower creatine phosphokinase (CK) and lactate dehydrogenase (LDH) levels. Both biomarkers are released from injured muscle tissue, making this variant a potential candidate for susceptibility to muscle-related symptoms. LILRB5/CD85c Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 74.06 kDa and the accession number is O75023-1.
Species Human
Expression Host HEK293 Cells
Tag C-hFc
Accession Number O75023-1
別名 LIR-8, LIR8, CD85C, leukocyte immunoglobulin like receptor B5
Construction The Human LILRB5 (NP_006831.1) (Met1-Gly458) was expressed with the Fc region of Human IgG1 at the C-terminus.
Protein Purity > 90 % as determined by SDS-PAGE.
分子量 74.06 kDa (predicted)
Endotoxin < 1.0 EU/μg of the protein as determined by the LAL method.
Formulation Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.4. Typically, a mixture containing 5% to 8% trehalose, mannitol, and 0.01% Tween 80 is incorporated as a protective agent before lyophilization.
Reconstitution A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information.
Stability & Storage

It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at-80℃. For reconstituted proteinsolutions, the solution can be stored at -20°c to -80'c for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.

Shipping

In general, Lyophilized powders are shipping with blue ice.

Research Background A genetic variant in LILRB5 (leukocyte immunoglobulin-like receptor subfamily-B) (rs12975366: T > C: Asp247Gly) has been reported to be associated with lower creatine phosphokinase (CK) and lactate dehydrogenase (LDH) levels. Both biomarkers are released from injured muscle tissue, making this variant a potential candidate for susceptibility to muscle-related symptoms.

Calculator

Reconstitution Calculator
Recombinant Proteins Dilute Calculator
Specific Activity Calculator
=
÷
X
=
X
(Unit/mg)
= 106 ÷
ng/mL

bottom

技術サポート

Please read the User Guide of Recombinant Proteins for more specific information.

Keywords

LILRB5/CD85c Protein, Human, Recombinant (hFc) LIR-8 LIR8 CD85C leukocyte immunoglobulin like receptor B5 LIR 8 recombinant recombinant-proteins proteins protein